Compare · DFTX vs HPCO
DFTX vs HPCO
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Hempacco Co. Inc. (HPCO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and HPCO operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX carries a market cap of $5.14B.
- DFTX has hit the wire 7 times in the past 4 weeks while HPCO has been quiet.
- DFTX has more recent analyst coverage (7 ratings vs 0 for HPCO).
- Company
- Definium Therapeutics Inc.
- Hempacco Co. Inc.
- Price
- $38.36+0.42%
- $0.62-11.65%
- Market cap
- $5.14B
- -
- 1M return
- -15.07%
- -
- 1Y return
- +292.43%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 7
- 0
- Recent ratings
- 7
- 0
Latest DFTX
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
- Chief Executive Officer Barrow Robert was granted 40,000 shares and sold $721,733 worth of shares (19,023 units at $37.94) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 1,494,640 units (SEC Form 4) (tax withholding)
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
- BofA Securities initiated coverage on Definium Therapeutics with a new price target
- Definium Therapeutics Announces New Employee Inducement Grants
- Amendment: SEC Form SCHEDULE 13G/A filed by Definium Therapeutics Inc.
- Chief Commercial Officer Wiley Matthew T. was granted 62,500 shares, increasing direct ownership by 36% to 237,133 units (SEC Form 4)
- Chief Medical Officer Karlin Daniel was granted 100,000 shares, increasing direct ownership by 20% to 603,282 units (SEC Form 4)
Latest HPCO
- Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities
- SEC Form NT 10-Q filed by Hempacco Co. Inc.
- SEC Form DEFA14A filed by Hempacco Co. Inc.
- SEC Form DEF 14A filed by Hempacco Co. Inc.
- Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 10-K filed by Hempacco Co. Inc.
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing